Storage and handling
Other Information Protect the product in this container from excessive heat and direct sun
No7 Beautiful Skin Day Cream Dry Very Dry Sunscreen Broad Spectrum SPF 15
- Manufacturer
- BCM Ltd | The Boots Company PLC
- Effective date
- 2020-01-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-05-31 23:04:00
Label at a glance#
ProductNo7 Beautiful Skin Day Dry Very Dry Sunscreen Broad Spectrum SPF 15
Active ingredientAvobenzone, Octisalate, Octocrylene
Label structure16 sections
Contacts and useful links#
Websitewww.boots.com
www.boots.com/no7
www.boots.com/no7Label contents#
Full prescribing information#
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Aqua (water), Glycerin, C12-15 alkyl benzoate, Dimethicone, Cetearyl alcohol, Cetearyl glucoside, Aluminum starch octenylsuccinate, Tribehenin, Ammonium acryloyldimethyltaurate/VP copolymer, Phenoxyethanol, Tocopheryl acetate, Butyrospermum parkii (Shea) butter, Potassium cetyl phosphate, Parfum (Fragrance), Methylparaben, Sodium PCA, Xanthan gum, Ethylparaben, Sodium lauroyl lactylate, Ascorbyl glucoside, Tetrasodium EDTA, Magnesium PCA, Dipropylene glycol, T-butyl alcohol, Zinc PCA, Biosaccharide gum-1, Ceramide 3, Potassium hydroxide, Ceramide 6 II, Ceramide 1, Phytosphingosine, Cholesterol, Carbomer, Manganese PCA, Ethylhexylglycerin, Simethicone, Potassium sorbate
OTC - QUESTIONS SECTION
USA: Questions? 1-866-75-BOOTS
The Boots Company PLC Nottingham England NG2 3AA
Dist. by Boots Retail USA Inc. Norwalk CT 06851 USA
Made in the UK
DESCRIPTION SECTION
A rich and intensive moisture cream to instantly nourish and provide hydration for 24 hours whilst leaving skin looking and feeling healthy and radiant.The protective power of SPF 15 and broad spectrum sunscreens give you advanced protection for the future and and help keep you looking as young as possible.
Hypo-allergenic: Because all skin can have sensitive moments all our products are hypo-allergenic, using ingredients we know and trust.
DESCRIPTION SECTION
For Best Results: Smooth into your face and neck after cleansing every morning for make-up ready skin.
Enriched with No7's unique multivitamin and mineral blend to help hydrate and energise skin plus a blend of replenishing lipids to help nourish dry skin and lock in moisture.
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients
Avobenzone 3%, Octisalate 2%, Octocrylene 4%
Purpose
Sunscreen
OTC - PURPOSE SECTION
Uses
Helps prevent sunburn
WARNINGS AND PRECAUTIONS SECTION
Warnings
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away
INSTRUCTIONS FOR USE SECTION
Directions
Apply liberally 15 minutes before sun exposure
Use a water resistant sunscreen if swimming or sweating
Reapply at least every 2 hours
Children under 6 months of age: ask a doctor
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun protection measures including:
limit time in the sun, especially from 10a.m. - 2p.m.
wear long-sleeved shirts, pants, hat and sunglasses
STORAGE AND HANDLING SECTION
Other Information
Protect the product in this container from excessive heat and direct sun
INSTRUCTIONS FOR USE SECTION
JAR TEXT
Smooth into your face and neck after cleansing every morning
WARNINGS SECTION
JAR TEXT
Warning: Avoid contact with eyes. If product gets into the eyes, rinse well with water immediately.
OTC - ACTIVE INGREDIENT SECTION
JAR TEXT
Active ingredients: Octocrylene 4%, Avobenzone 3%, Octisalate 2%.
INFORMATION FOR PATIENTS SECTION
JAR TEXT
The Boots Company PLC
Nottingham England NG2 3AA
Dist. in the USA by Boots Retail USA Inc.
Norwalk CT 06851 USA
Made in the UK
Carton
carton
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 11489-072-01 | 2022-01-28 | C162847 | 48780-1 | 97449f38-b696-f6ea-e053-dbdaa90aa703 | No7 Beautiful Skin Day Cream Dry Very Dry Sunscreen Broad Spectrum SPF 15 |
| 11489-072-01 | 2020-03-18 | C162847 | 48780-1 | 97449f38-b696-f6ea-e053-dbdaa90aa703 | No7 Beautiful Skin Day Cream Dry Very Dry Sunscreen Broad Spectrum SPF 15 |
| 11489-072-01 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b696-f6ea-e053-dbdaa90aa703 | No7 Beautiful Skin Day Cream Dry Very Dry Sunscreen Broad Spectrum SPF 15 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11489-072-01 | No7 Beautiful Skin Day Dry Very Dry Sunscreen Broad Spectrum SPF 15 | 1 in 1 CARTON | CREAM | 1 | 2 | |
| 11489-072-01 | No7 Beautiful Skin Day Dry Very Dry Sunscreen Broad Spectrum SPF 15 | 50 mL in 1 JAR | CREAM | 50 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11489-072 | NO7 BEAUTIFUL SKIN DAY DRY VERY DRY SUNSCREEN BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) CREAM [BCM LTD] | 2 | Legacy NDC, 2 package rows | 20200318_829073a2-e962-400e-a070-5b2946e66f40.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Avobenzone | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| Octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| Octocrylene | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| Avobenzone | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| Octisalate | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| Octocrylene | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| ALUMINUM STARCH OCTENYLSUCCINATE | INACTIVE INGREDIENT | I9PJ0O6294 | 1 | |
| AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER | INACTIVE INGREDIENT | W59H9296ZG | 1 | |
| ASCORBYL GLUCOSIDE | INACTIVE INGREDIENT | 2V52R0NHXW | 1 | |
| BIOSACCHARIDE GUM-1 | INACTIVE INGREDIENT | BB4PU4V09H | 1 | |
| CERAMIDE 1 | INACTIVE INGREDIENT | 5THT33P7X7 | 1 | |
| CERAMIDE 3 | INACTIVE INGREDIENT | 4370DF050B | 1 | |
| CERAMIDE 6 II | INACTIVE INGREDIENT | F1X8L2B00J | 1 | |
| CETEARYL GLUCOSIDE | INACTIVE INGREDIENT | 09FUA47KNA | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| CHOLESTEROL | INACTIVE INGREDIENT | 97C5T2UQ7J | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| DIPROPYLENE GLYCOL | INACTIVE INGREDIENT | E107L85C40 | 1 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 1 | |
| ETHYLHEXYLGLYCERIN | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| MAGNESIUM PIDOLATE | INACTIVE INGREDIENT | V5PC588N7G | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POTASSIUM CETYL PHOSPHATE | INACTIVE INGREDIENT | 03KCY6P7UT | 1 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| SHEA BUTTER | INACTIVE INGREDIENT | K49155WL9Y | 1 | |
| SODIUM LAUROYL LACTYLATE | INACTIVE INGREDIENT | 7243K85WFO | 1 | |
| SODIUM PYRROLIDONE CARBOXYLATE | INACTIVE INGREDIENT | 469OTG57A2 | 1 | |
| TERT-BUTYL ALCOHOL | INACTIVE INGREDIENT | MD83SFE959 | 1 | |
| TRIBEHENIN | INACTIVE INGREDIENT | 8OC9U7TQZ0 | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 | |
| ZINC PIDOLATE | INACTIVE INGREDIENT | C32PQ86DH4 | 1 |
Products#
Every source-derived product name is available through these pages.
- No7 Beautiful Skin Day Dry Very Dry Sunscreen Broad Spectrum SPF 15
- Avobenzone, Octisalate and Octocrylene
- Avobenzone
- Octisalate
- Octocrylene
- Water
- GLYCERIN
- ALKYL (C12-15) BENZOATE
- Dimethicone
- CETOSTEARYL ALCOHOL
- CETEARYL GLUCOSIDE
- ALUMINUM STARCH OCTENYLSUCCINATE
- TRIBEHENIN
- AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER
- PHENOXYETHANOL
- .ALPHA.-TOCOPHEROL ACETATE
- SHEA BUTTER
- POTASSIUM CETYL PHOSPHATE
- METHYLPARABEN
- SODIUM PYRROLIDONE CARBOXYLATE
- XANTHAN GUM
- ETHYLPARABEN
- SODIUM LAUROYL LACTYLATE
- ASCORBYL GLUCOSIDE
- EDETATE SODIUM
- MAGNESIUM PIDOLATE
- DIPROPYLENE GLYCOL
- TERT-BUTYL ALCOHOL
- ZINC PIDOLATE
- BIOSACCHARIDE GUM-1
- CERAMIDE 3
- POTASSIUM HYDROXIDE
- CERAMIDE 6 II
- CERAMIDE 1
- CHOLESTEROL
- ETHYLHEXYLGLYCERIN
- POTASSIUM SORBATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 11489-072 | 11489-072-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION, EXTENDED RELEASE / ORAL | 186.8 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SOLUTION / TOPICAL | 0.3 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SPRAY, METERED / NASAL | 0.06 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | SOLUTION / ORAL | 14 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CAPSULE / ORAL | 7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | INJECTION / INTRAMUSCULAR | 0.01 %w/v | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | CAPSULE, EXTENDED RELEASE / ORAL | 9.43 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / EPIDURAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SOLUTION / ORAL | 10 mg/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / TOPICAL | 216 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GEL / TOPICAL | 24 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | 30 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | CREAM / TOPICAL | 46 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / TOPICAL | 0.11 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER / ORAL | NA | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET / ORAL | 6 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| ALUMINUM STARCH OCTENYLSUCCINATE | ALUMINUM STARCH OCTENYLSUCCINATE | I9PJ0O6294 | CREAM / TOPICAL | 321 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| CHOLESTEROL | CHOLESTEROL | 97C5T2UQ7J | LOTION / TOPICAL | 20 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / INTRAVENOUS | 0.13 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET / ORAL | 1.8 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ELIXIR / ORAL | 800 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRALESIONAL | 0.15 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| CHOLESTEROL | CHOLESTEROL | 97C5T2UQ7J | CREAM / TOPICAL | 1 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ENEMA / RECTAL | 0.18 %w/v | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SOAP / TOPICAL | 0.12 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, EXTENDED RELEASE / ORAL | 0.17 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | GEL / TOPICAL | 3 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SOLUTION / ORAL | 84 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / OPHTHALMIC | 2 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / NASAL | 26 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUPPOSITORY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| SODIUM PYRROLIDONE CARBOXYLATE | SODIUM PYRROLIDONE CARBOXYLATE | 469OTG57A2 | LOTION / TOPICAL | 42 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / ORAL | 360 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | POWDER, FOR SUSPENSION / ORAL | 600 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / TOPICAL | 1428 mg | ||
| CHOLESTEROL | CHOLESTEROL | 97C5T2UQ7J | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 0.32 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAVENOUS | 95 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | GRANULE, FOR SUSPENSION / ORAL | 80 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8b9ff0f1-3e55-424d-bce9-54b3634828b5 | 829073a2-e962-400e-a070-5b2946e66f40 | 2020-01-09 | Warnings | 8b9ff0f1-3e55-424d-bce9-54b3634828b5 829073a2-e962-400e-a070-5b2946e66f40 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.